SUBMIT YOUR RESEARCH
Scholars International Journal of Traditional and Complementary Medicine (SIJTCM)
Volume-7 | Issue-09 | 124-126
Review Report
Comparative Evaluation of Kanchnar Guggulu and Cystogrit Diamond in Stanagranthi (Fibroadenoma Breast)
Dr. Mansi, Dr. Saurabh Sharma, Prof. (Dr.) Sachin Gupta
Published : Oct. 9, 2024
DOI : DOI: https://doi.org10.36348/sijtcm.2024.v07i09.002
Abstract
Fibroadenoma is a benign breast tumor common in young women, affecting their daily life. Modern medicine often recommends surgical intervention, which can have physical and emotional consequences. The study explores alternative treatments through Ayurveda, which offers non-invasive and cost-effective options. This study investigates the comparative efficacy of Kanchnar Guggulu and Cystogrit Diamond in the management of Stanagranthi (Fibroadenoma breast). Sixty patients were randomly divided into two groups: Group A (treated with Kanchnar Guggulu) and Group B (treated with Cystogrit Diamond). The study assessed subjective (pain, consistency) and objective (size, number of lumps) parameters before and after a 90-day treatment period. The study aims to provide a safe, effective alternative to surgery for managing fibroadenoma, with Ayurveda offering promising non-invasive treatments. Results showed a significant reduction in pain for both groups, with Group B demonstrating a 93.24% improvement compared to Group A's 83.93%. In terms of lump size reduction, Group B also outperformed Group A, with a 42.86% decrease versus 29.85%, respectively. The average effect on consistency was higher in Group B (31.58%) compared to Group A (25%). The findings suggest that Cystogrit Diamond is more effective than Kanchnar Guggulu in managing Stanagranthi, providing a potential non-invasive, cost-effective alternative to surgery for fibroadenoma patients.
Scholars Middle East Publishers
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Copyright Scholars Middle East Publisher. All Rights Reserved.